QR6-12839-44790
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 018 / MA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Registered in v-safe
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-03-02
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-04
- 2021-03-05
- 2021-03-07
- 2021-03-16
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-28
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-13
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-06-22
- 2021-09-19
-
2022-03-23
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Migraine, Paranasal sinus discomfort, Pyrexia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Fever, sinus pressure, migraine, loss of sense of taste and smell. · Healthcare visit (other): NoneMedDRA releases: 2024-11 · check-in free text available
-
2022-03-23
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: Fever, sinus pressure, migraine, loss of sense of taste and smell.
Healthcare visit (other): None
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release